Cleveland, TN, United States of America

Jesse Calvin Hayes, Jr

This inventor holds 2 USPTO granted patents. Top assignee: Schering-Plough Healthcare Products Inc.. Active years: 1995-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jesse Calvin Hayes, Jr. Retrieved from https://idiyas.com/inventor/jesse-calvin-hayes-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1995-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jesse Calvin Hayes, Jr.

Introduction

Jesse Calvin Hayes, Jr. is an accomplished inventor based in Cleveland, TN (US). He has made significant contributions to the field of medicine, particularly in the treatment of onychomycosis. With a total of 2 patents to his name, Hayes has developed innovative methods that enhance the treatment options available for this condition.

Latest Patents

Hayes' latest patents focus on a treatment for onychomycosis through the topical application of salicylic acid. This method involves using salicylic acid, optionally in combination with a retinoid, to create a medicament for treating the condition. The active ingredient can be delivered in various forms, such as a plaster or liquid preparation. Notably, this method allows for the treatment of the afflicted nail without the need for drilling holes or scraping the nail, and it does not involve the use of imidazole antimycotic compounds.

Career Highlights

Throughout his career, Hayes has worked with Schering-Plough Healthcare Products Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in dermatological treatments, particularly for fungal infections affecting the nails.

Collaborations

Hayes has collaborated with notable colleagues, including Gerald R. Dever and Thomas J. Laughlin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of effective treatment methods.

Conclusion

Jesse Calvin Hayes, Jr. stands out as a significant figure in the field of medical innovation. His contributions to the treatment of onychomycosis demonstrate his commitment to improving patient care through effective and non-invasive methods. His work continues to influence the medical community and offers hope for those affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…